Dialectical Behavior Therapy for Adults with Autism Spectrum Disorders
Dialectical Behavior Therapy for Adults With Autism Spectrum Disorders Without Intellectual Disability: a Randomized Controlled Trial
This study is testing if Dialectical Behavior Therapy can help adults with Autism Spectrum Disorders who struggle with emotions and self-harm feel better and improve their mental health.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 48 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Strasbourg, France Academic / other |
| Locations | 1 site (Strasbourg) |
| Trial ID | NCT04737707 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effectiveness of Dialectical Behavior Therapy (DBT) in reducing emotional dysregulation and self-harm behaviors in adults diagnosed with Autism Spectrum Disorders (ASD) who do not have intellectual disabilities. The study will involve a randomized controlled design over a 5-month period, focusing on participants who have experienced suicidal thoughts or self-harm in the six months prior to enrollment. The aim is to assess whether DBT can provide significant improvements in emotional regulation and overall mental health for this population.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older with a diagnosis of ASD, an IQ of 70 or above, and a history of self-harm or suicidal behaviors.
Not a fit: Patients currently undergoing other forms of therapy such as CBT or DBT, or those with schizophrenia disorders, may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve emotional regulation and reduce self-harm behaviors in adults with ASD.
How similar studies have performed: While DBT has been effective in treating various disorders, this specific application for adults with ASD is novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * ≥ 18 years old * ASD diagnosis according to the DSM-5 * IQ ≥ 70 * Suicidal ideas, suicidal attempts and/or self-harm behaviors 6 months prior to the inclusion * Able to understand and consent to the research aims * Membership in a health insurance fund Exclusion Criteria: * complete hospitalization * ongoing CBT or DBT * past DBT * schizophrenia disorders * under guardianship
Where this trial is running
Strasbourg
- Service de psychiatrie — Strasbourg, France (Recruiting)
Study contacts
- Study coordinator: Luisa WEINER, MD
- Email: weiner.l@gmail.com
- Phone: 03 88 11 65 11
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.